• Hausa Edition
  • Podcast
  • Conferences
  • LeVogue Magazine
  • Business News
  • Print Advert Rates
  • Online Advert Rates
  • Contact Us
Wednesday, September 10, 2025
Leadership Newspapers
Read in Hausa
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
Leadership Newspapers
No Result
View All Result

AHF, Stakeholders Task Pharma Coys On Access To HIV, Hepatitis Drugs

…Seek license technology for production to generic manufacturers

by Jerry Emmanson
2 years ago
in News
Reading Time: 3 mins read
AHF
Share on WhatsAppShare on FacebookShare on XTelegram

RELATED

IATF 2025: Zamfara Is Open For Investment, Governor Lawal Tells Global Investors

IATF 2025: Zamfara Is Open For Investment, Governor Lawal Tells Global Investors

1 hour ago
Group Lauds NASS Over Bill To Establish Chemical Technology Institute

Federal Government, Governors Push Skills Council Bill To NASS

3 hours ago
Aids Health Foundation (AHF) and stakeholders in the health sector have called on top pharmaceutical companies in the world to reduce the cost of HIV and Hepatitis C drugs.
The call according to them will enable patients in developing countries to have access to the drug.
At the event in Abuja held on Tuesday April 4, AHF said pharmaceutical firms like Gilead Sciences, is one of the offenders putting profits before people’s lives, by allegedly refusing to register some drugs in developing countries and consistently blocking attempts to introduce cheaper, generic versions of its medicines.
The Foundation called on the firm to stop evergreening patents on HIV/AIDS drugs like Truvada and also open the license for the generic production of Hepatitis C drug, Harvoni to all low- and middle-income countries.
During the press briefing, AHF Country Program Director, Dr. Echie Ijezie in his address said AHF has a long-running history of advocating and challenging Gilead on its profiteering from the most vulnerable and ill people globally.
He said; “Gilead all too often buys up publicly funded research on new medicines, brings them to market at inflated prices, and rewards its executives with enormous pay packages while delivering above-market stock prices and dividends for its shareholders.”
He said AHF is taking its grassroots campaign global to raise awareness about the shameful practices and calling on the company to sell or licence remdesivir for generic distribution at a non-profit price. He also demanded licence technology for the production of treatment for cryptococcal meningitis to generic manufacturers.
Ijezie said if this is carried out, there will be improved access and the commodities will be affordable, and a lot more countries will be able to manufacture the generic version of these drugs at a cheaper rate.
“Patient communities that are affected stand to benefit a lot, and in the sense that these drugs become more accessible, affordable and even if there are new infections there would not be that worry of the high cost of treatment, particularly with reference to Hepatitis C,” he added.
Also speaking, AHF Africa Bureau, Director of Advocacy, Policy & Marketing, Kemi Gbadamosi, maintained that over the past years, Gilead has been criticized for blocking access to affordable treatment of cryptococcal meningitis – a potentially deadly fungal disease that often affects people living with HIV.
“Gilead holds a patent on the technology needed to produce the drug; therefore, generic manufacturers cannot produce it at a lower cost”.
“Gilead has promised but failed to deliver on a commitment to provide the drug to 116 countries at $16 per vial and has not even registered the drug in these countries, relying instead on local suppliers in countries like India and South Africa, with the price in low- and middle-income countries ranging from $70-$200 per vial.
NINERELA Exective Secretary, Amber Erinmwinhe, on her part said open market is the best way to create access to the drugs and give room for production.
She added that it will reduce the cost of drugs and help low income earners to patronize.
--> Join Our WhatsApp Channel

Tags: Aids Health Foundation (AHF)HIV
SendShare10167Tweet6355Share
ADVERTISEMENT
Previous Post

Zulum Approves APCs, Patrol Vehicles For Soldiers In Malam-Fatori

Next Post

Elon Musk Overtaken By Arnault As World’s Richest Man

Jerry Emmanson

Jerry Emmanson

You May Like

IATF 2025: Zamfara Is Open For Investment, Governor Lawal Tells Global Investors
News

IATF 2025: Zamfara Is Open For Investment, Governor Lawal Tells Global Investors

2025/09/10
Group Lauds NASS Over Bill To Establish Chemical Technology Institute
News

Federal Government, Governors Push Skills Council Bill To NASS

2025/09/09
Macron Appoints Sébastien Lecornu As New Prime Minister After Bayrou’s Ouster
News

Macron Appoints Sébastien Lecornu As New Prime Minister After Bayrou’s Ouster

2025/09/09
FCT Police Warn Against Use Of Covered Plate Number, Tinted Glass
News

Summon: Police Insist On El-Rufai, Others’ Personal Appearance

2025/09/09
Constituents Divided Over Plot To Recall Natasha
News

‘Stopping Natasha From Resumption Unlawful”, Adegboruwa Tells Senate

2025/09/09
NUPENG Tasks Members on Unity
News

JUST-IN: NUPENG Suspends Strike As Dangote, Union Sign MoU On Workers’ Unionisation

2025/09/09
Leadership Conference advertisement

LATEST

IATF 2025: Zamfara Is Open For Investment, Governor Lawal Tells Global Investors

Federal Government, Governors Push Skills Council Bill To NASS

Macron Appoints Sébastien Lecornu As New Prime Minister After Bayrou’s Ouster

Summon: Police Insist On El-Rufai, Others’ Personal Appearance

‘Stopping Natasha From Resumption Unlawful”, Adegboruwa Tells Senate

South Africa Maintain Lead, Share Points With Nigeria In Thrilling World Cup Qualifier

JUST-IN: NUPENG Suspends Strike As Dangote, Union Sign MoU On Workers’ Unionisation

2027: Bayelsa APC Endorses Tinubu For Reelection

PICTORIAL: Late Ajimobi’s Widow Visits Olubadan-designate Oba Ladoja

12 Die, 8 Injured In Imo Road Crash

© 2025 Leadership Media Group - All Rights Reserved.

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us

© 2025 Leadership Media Group - All Rights Reserved.